Martha C. Townsend, BS – Principal

Ms. Townsend has over 20 years of commercial and operations experience in the clinical diagnostics industry with a specialty in personalized medicine. Her experience in defining product positioning and sales commercial execution in a complex market is evidenced by the fact that she has launched more than eight companion diagnostic products and multiple breakthrough products. In 1998, she launched the first companion diagnostic, HercepTest, to select women with end stage breast cancer who were likely to benefit from Herceptin. Ms. Townsend has successfully supported biotechnology, device, and diagnostic companies in planning and implementing commercial launches. Her capabilities include market planning, business development, and commercial launch activities for success in the diagnostic marketplace. Ms. Townsend has held management positions at Siemens Healthcare Diagnostics, Inc. (previously Chiron Diagnostics) and Dako, Inc., leading teams in complex commercial launches requiring an integrated launch of both diagnostic and pharmaceutical products. She was also responsible for international marketing, sales and service in European and Latin American markets implementing export market objectives, analyzing sales activities and market conditions, and selecting distributors. Ms. Townsend holds a BS in Biology from Loyola Marymount University of Los Angeles, California and a Medical Marketing Certificate from the University of California, Los Angeles Anderson School of Business. She is fluent in Spanish.

< Back to Team